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Abstract The purpose of this investigation was to identify
when diagnostic testing and empirical antiviral therapy
should be considered for adult patients requiring hospital-
ization during influenza seasons. During the 2007/8 influ-
enza season, six acute care hospitals in the Greater Toronto
Area participated in active surveillance for laboratory-
confirmed influenza requiring hospitalization. Nasopharyn-
geal (NP) swabs were obtained from patients presenting
with acute respiratory or cardiac illness, or with febrile
illness without clear non-respiratory etiology. Predictors of
influenza were analyzed by multivariable logistic regression
analysis and likelihoods of influenza infection in various
patient groups were calculated. Two hundred and eighty of
3,917 patients were found to have influenza. Thirty-five
percent of patients with influenza presented with a triage
temperature ≥38.0°C, 80% had respiratory symptoms in the
emergency department, and 76% were ≥65 years old.
Multivariable analysis revealed a triage temperature
≥38.0°C (odds ratio [OR] 3.1; 95% confidence interval
[CI] 2.3–4.1), the presence of respiratory symptoms (OR
1.7; 95% CI 1.2–2.4), admission diagnosis of respiratory
infection (OR 1.8; 95% CI 1.3–2.4), admission diagnosis of
exacerbation of chronic obstructive pulmonary disease
(COPD)/asthma or respiratory failure (OR 2.3; 95% CI
1.6–3.4), and admission in peak influenza weeks (OR 4.2;
95% CI 3.1–5.7) as independent predictors of influenza.
The likelihood of influenza exceeded 15% in patients with
respiratory infection or exacerbation of COPD/asthma if the
triage temperature was ≥38.0°C or if they were admitted in
the peak weeks during the influenza season. During
influenza season, diagnostic testing and empiric antiviral
therapy should be considered in patients requiring hospi-
talization if respiratory infection or exacerbation of COPD/
asthma are suspected and if either the triage temperature is
≥38.0°C or admission is during the weeks of peak influenza
activity.
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The primary strategy for the protection of Canadians
against influenza is immunization. In healthy adults,
vaccination is about 80% effective against infection due to
influenza when the vaccine is antigenically well matched to
circulating virus [1]. In older adults, vaccination is
substantially less effective; nonetheless, it has still been
shown in randomized controlled trials to offer substantial
protection [2, 3]. Annual influenza vaccine is provided free-
of-charge to all residents of Ontario. Overall, 42% of
Ontarians aged 12 years or older and 71% of residents over
64 years of age are vaccinated against influenza annually
[4]. Despite these rates of annual immunization, influenza
remains the most common infectious cause of death in
Ontario, with an estimated 1,300 to 2,700 deaths annually
in a population of approximately 11 million [5, 6].
In healthy adult outpatients, if treatment is started with a
neuraminidase inhibitor within 48 h of symptom onset, the
severity and duration of illness due to influenza can be
reduced by 25–35% and the rate of complications by 40–
65% [7, 8]. Several observations suggest that the benefits of
treating influenza in immunocompromised patients, or
those with severe illness requiring hospitalization, may be
even greater [9, 10]. However, prior to the 2009 pandemic,
influenza testing was rarely performed in severely ill adults
in Ontario, and sensitive and specific tests whose results are
available in a timely manner were not accessible in most
hospitals. Although clinical algorithms with reasonable
positive predictive values for influenza exist for healthy,
young adults, no such algorithms exist for patients
requiring hospitalization [11, 12].
The aims of this study were to describe the epidemiology
of severe influenza in a highly vaccinated population, to
identify predictors of influenza infection in adult patients
requiring hospitalization in Toronto during the 2007/
8 influenza season, and to determine when viral testing
and empiric antiviral therapy should be considered in
patients requiring hospitalization during influenza seasons.
Materials and methods
Setting and maneuver
The Toronto Invasive Bacterial Diseases Network (TIBDN)
is a collaborative network of microbiology laboratories,
infection-control practitioners, and public health depart-
ments that performs population-based surveillance for
infectious diseases in south-central Ontario. During the
2007/8 influenza season, six (two tertiary care and four
community) acute care hospitals from the TIBDN partici-
pated in active surveillance for laboratory-confirmed
influenza requiring hospitalization. All admissions to
medical or medical/surgical intensive care units (ICUs) in
all six hospitals and all admissions to medical services in
four hospitals were eligible for surveillance. Prior to the
influenza season, attending physicians in all departments
agreed that, during the influenza season, nasopharyngeal
(NP) swabs were clinically indicated in patients requiring
hospital or ICU admission who presented with any acute
respiratory or cardiac illness (independent of body temper-
ature), or with any febrile illness without clear, non-
respiratory etiology. During the influenza season, study
staff screened all admissions daily and suggested orders for
NP swabs in all patients with any acute cardiac or
respiratory illness, or any febrile illness without a clear
non-respiratory source who had not yet had them ordered.
Demographic and medical information was collected from
each patient by chart review; the admission diagnosis was
as recorded in each chart. NP swabs were tested for the
presence of influenza by direct fluorescent antigen (DFA)
detection or enzyme immunoassay (EIA) on-site in 5 of 6
hospitals, and by polymerase chain reaction (PCR) and
viral culture at the Ontario Public Health Laboratory for all
specimens.
For the purposes of the study, the influenza season was
defined as starting when the proportion of positive
influenza tests among specimens submitted to the Ontario
Public Health Laboratory for viral testing was greater than
5% for two consecutive weeks, and ending when the
proportion of positive tests was below 5%; the peak season
was defined as any week in which the proportion of
submitted specimens yielding influenza was >15%. For
logistical reasons, although the season was identified as
starting on December 16th, 2007, the start of the surveil-
lance was postponed to December 30th (the first day of
week 1 of 2008).
Statistical analyses
Data were double entered and cleaned, then manually
inspected for errors and outlying values, which were then
confirmed or corrected with original records. The data were
analyzed in SAS, version 9.1 for PC (SAS Institute, Cary,
NC). Differences in group proportions were assessed by the
χ
2 test or Fisher’s exact test, and differences in medians
were calculated with the Wilcoxon rank-sum test. Like-
lihoods were calculated as binomial proportions with 95%
confidence intervals. A multivariable logistic regression
analysis was performed to evaluate predictors of influenza.
An estimated minimum number of 200 events was a priori
determined to ensure an acceptable sample size for the
given number of predictor variables in the model. All
variables with a p-value <0.1 in univariable analysis were
considered for inclusion in the multivariable model.
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influenza types and admission to ICU vs. medical ward to
ensure that potential clinically important effects of these
variables were not missed in the pooled analysis. Missing
values were excluded throughout the analyses.
Ethics approval
The study was approved by the Research Ethics Boards of
all participating hospitals.
Results
Influenza season
The influenza season in Toronto in 2007/8 was bi-modal,
with a first “season” beginning on December 16th, 2007
(week 51) and ending February 3th, 2008 (week 6), and a
second “season” beginning on February 24th, 2008 (week
9) and ending on May 3rd, 2008 (Fig. 1)[ 13]. Influenza
activity was predominantly influenza A(H1N1) until week
7 of 2008. From week 8 to week 21, activity was mixed
influenza A(H3N2) and influenza B. Overall in Canada,
39.1% of the samples tested were influenza A(H1N1),
13.1% were influenza A(H3N2), and 44.8% were influenza
B[ 14]. The percentage of specimens yielding influenza was
highest during weeks 8 to 21, when there was significant
antigenic mismatch between both circulating influenza
strains (A(H3N2) and B) and the antigens in the 2007
northern hemisphere influenza vaccine.
Results of surveillance
From December 30th, 2007, through May 24th, 2008,
6,236 eligible patients were admitted to participating
hospitals/ICUs. Of these, 3,917 (62.8%) were tested for
influenza infection and 280 (7.1% of those tested) were
identified as infected with influenza (Fig. 2). DFA was
positive for influenza in 3.1% (37/1,200) of tests submitted,
EIA in 2.6% (44/1,708), viral culture in 4.5% (172/3,834),
and PCR in 6.9% (245/3,567). Among patients with at least
one test positive for influenza, DFA was positive in 53.6%
(37/69), EIA in 29.7% (44/148), viral culture in 62.1%
(172/277), and PCR in 98.4% (245/249). All specimens
positive by EIA or DFA were also positive by culture and
PCR, with the exception of 1 of 44 (2.3%) specimens
positive by EIA that was negative by both culture and PCR
(DFA was not performed). Similarly, of 174 specimens
positive by culture, 171 were positive by PCR, one was
negative, and two were PCR-indeterminate.
Specimens were more likely to be submitted in eligible
patients if the triage temperature was ≥38.0°C (76% [523/
688] vs. 62.7% [3,143/5,015] from patients with a triage
temperature <38.0°C, p<0.0001), if the patient reported
respiratory symptoms in the emergency department (67.8%
[2,288/3,374] vs. 60.3% [1,420/2,354] of those without
respiratory symptoms, p<0.0001), and if the admitting
diagnosis was pneumonia, other respiratory infection,
respiratory failure, exacerbation of asthma or chronic
obstructive pulmonary disease (COPD) (75.6% [1,140/
1,507] vs. 58.7% [2,777/4,729] in patients with other
admission diagnoses, p<0.0001).
The temporal variation in the percentage of specimens
yielding influenza in specimens from this study paralleled
the yield in specimens submitted to the Ontario Public
Health Laboratory: study hospitals: 2.9% positive tests in
weeks 1–7 vs. 9.3% positive tests in weeks 8–21; Ontario
surveillance: 7.7% positive tests in weeks 1–7 vs. 18.2%
positive tests in weeks 8–21 (p=0.23). Patients with
influenza admitted early during the influenza season (weeks
1–7, when A(H1N1) predominated) were significantly
younger than those admitted later in the season (weeks 8–
21) (median 68.0 years [IQR: 53.7–80.4 years] during
weeks 1–7 vs. 81.8 years [IQR: 69.5–87.6 years] during
weeks 8–21, p=0.0005). There were no other differences in
patient characteristics between patients admitted during
weeks 1–7 and those admitted during weeks 8–21 (data not
shown).
Predictors of influenza infection
Table 1 shows the proportions of patients with influenza
among those admitted to participating medical wards or
ICUs according to the patient characteristics. Overall,
35.1% (94/268) of patients with influenza had a first
temperature taken at triage in the emergency department
(“triage temperature”) that was ≥38.0°C, and 40.1% (68/
167) had a maximum temperature ≥38.0°C during their first
24 h of admission. The majority (80.1%, 222/277) of
patients with influenza reported respiratory symptoms in
the emergency department, 75.7% (212/280) were 65 years
or older, and 56.6% (164/280) were admitted with an initial
diagnosis of respiratory infection, exacerbation of asthma or
COPD, respiratory failure, or sepsis. Multivariable analysis
revealed a triage temperature ≥38.0°C, the presence of
respiratory symptoms in the emergency department, an
admission diagnosis of respiratory infection (including
“pneumonia” and “other respiratory infection”), an admis-
sion diagnosis of underlying lung disease (including
“exacerbation of COPD”, “exacerbation of asthma”, and,
in ICU patients, “respiratory failure”), and admission in
weeks with >15% of surveillance specimens positive for
influenza as independent predictors for an infection due to
influenza A or B (Table 2). Admitting diagnosis of
underlying lung disease turned out to be a predictor of
Eur J Clin Microbiol Infect Dis (2010) 29:835–843 837influenza infection in patients <65 years old (OR 5.4; 95%
CI 2.7–11.0), but not in those ≥65 years of age (OR 1.5;
95% CI 0.9–2.5). No other differences in influenza
predictors were identified between these two age groups
(data not shown).
Predictors of influenza according to influenza type
Eighty-five of 136 (62.5%) influenza A strains were
available for subtyping: 18 were influenza A(H1N1) and
67 were influenza A(H3N2). The results of univariable and
multivariable analyses of influenza predictors performed for
influenza A(H3N2) and influenza B are shown in Table 3.
Influenza A(H1N1) was not included in the subanalysis due
to the small number of case patients. In contrast to
influenza A(H3N2), a diagnosis of influenza B was
significantly more likely in patients with an admission
diagnosis of pneumonia or other respiratory infection,
exacerbation of asthma/COPD, or, in ICU patients, respi-
ratory failure.
Likelihood of influenza in different patient groups
Table 4 depicts the likelihoods of influenza in various
patient groups. The likelihood of influenza exceeded 30%
in patients admitted during peak influenza weeks who had a
fever at triage and who had either a diagnosis of respiratory
tract infection, exacerbation of COPD or asthma, or
complained of any respiratory symptoms in the emergency
department. It exceeded 15% in patients with respiratory
Fig. 1 Comparison of influenza
activity by laboratory surveil-
lance in Ontario expressed as
the percentage of specimens
submitted to reference virology
laboratories yielding influenza
(bars) and the percentage of
screened patient admissions to
medical wards and intensive
care units (ICUs) of participat-
ing hospitals in Toronto positive
for influenza (lines) during the
2007/8 influenza season
838 Eur J Clin Microbiol Infect Dis (2010) 29:835–843infections or exacerbations of COPD/asthma if the triage
temperature was ≥38.0°C at any time during the season or
during peak weeks (i.e., weeks with >15% of surveillance
specimens positive) with any triage temperature.
However, in weeks with <15% specimens positive (off-
peak weeks) or if the admitting diagnosis was something
other than a respiratory infection or an exacerbation of
COPD/asthma, the likelihood of influenza dropped below
10%, even in febrile patients with respiratory symptoms.
Similarly, afebrile patients with respiratory infections or
obstructive pulmonary disorders had a low likelihood of
influenza infection if admission was during off-peak weeks.
The likelihood of influenza was below 2% in afebrile
patients with respiratory symptoms during off-peak weeks
when the admitting diagnosis was something other than
respiratory infections or exacerbation of chronic lung
disease.
Discussion
In prospective surveillance for laboratory-confirmed influ-
enza infection in patients admitted to six participating
hospitals in Toronto during the 2007/8 influenza season, a
Fig. 2 Flow chart of study subjects admitted to the medical wards and
ICUs of six acute care hospitals in Toronto during the 2007/8 influenza
season
Characteristics No. of influenza-positive/total (%)
Medical admissions (n=2,637) ICU admissions (n=1,280)
Gender
Male 96/1,208 (7.9%) 34/687 (4.9%)
Female 113/1,416 (7.9%) 37/591 (6.2%)
Age group
14–44 years 18/192 (9.4%) 3/93 (3.2%)
45–64 years 28/448 (6.3%) 19/356 (5.3%)
65–84 years 78/1,219 (6.4%) 36/664 (5.4%)
≥85 years 85/776 (10.9%) 13/167 (7.8%)
Temperature (°C) at triage
<37.0 67/1,547 (4.3%) 34/788 (4.3%)
37.0–37.9 58/556 (10.4%) 15/252 (6.0%)
38.0–38.5 42/209 (20.1%) 12/74 (16.2%)
>38.5 32/175 (18.3%) 8/65 (12.3%)
Respiratory symptoms in ED
No 46/999 (4.6%) 9/421 (2.1%)
Yes 160/1,531 (10.5%) 62/757 (8.2%)
Admission diagnosis
Respiratory infection
a 79/592 (13.3%) 22/184 (12.0%)
Exacerbation of asthma/COPD 30/241 (12.4%) 8/53 (15.1%)
Respiratory failure NOS - 9/70 (12.9%)
Sepsis NYD 13/127 (10.2%) 3/74 (4.1%)
Diabetes 3/24 (12.5%) 0/16 (0.0%)
Febrile neutropenia 5/41 (12.2%) -
Arrhythmia 7/129 (5.4%) 4/124 (3.2%)
Other respiratory diagnosis 8/142 (5.6%) 3/47 (6.3%)
Other cardiac diagnosis 13/571 (2.3%) 14/544 (2.6%)
Other diagnosis 51/770 (6.6%) 8/167 (4.8%)
Table 1 Characteristics of
patients screened for influenza
who were admitted to medical
wards and intensive care units
(ICUs) in participating hospitals,
Toronto, 2007/8 influenza season
Abbreviations: ED: emergency
department; COPD: chronic ob-
structive pulmonary disease;
NOS: not otherwise specified;
NYD: not yet diagnosed
aRespiratory infection includes:
pneumonia, acute bronchitis,
croup, and other lower respiratory
tract infection
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symptoms, admission diagnosis of respiratory infection, or
exacerbation of COPD or asthma, and admission during
peak influenza weeks were independent predictors for
influenza. The likelihood of influenza exceeded 15% in
patients with suspected respiratory infection or exacerbation
of COPD/asthma if they were admitted in peak weeks
during the influenza season, and exceeded 20% for patients
who were febrile at triage and had a respiratory diagnosis or
respiratory symptoms in the emergency department. These
findings may assist clinicians in decisions regarding
influenza testing of patients being hospitalized, and may
better guide decisions regarding empiric antiviral therapy in
adult acute care.
Our data suggest that these findings hold true for both
influenza A and B, for both younger and older adults, and
in patients being admitted to both medical services and
ICUs. While they are limited to a single geographic area
during a single influenza season, they are similar to those
from previous studies in other years in both North America
and Europe. Walsh et al., in a single hospital over three
influenza seasons from 2001–2004, identified that 154 of
1471 (10.5%) older adults admitted with a cardiopulmonary
diagnosis during the influenza season had influenza, and
that fever was more than twice as common in patients with
influenza as patients without [15]. van den Dool et al.,
during the peaks of two influenza seasons, identified that
8.5% of patients (23 of 271) admitted to internal medicine,
Table 3 Predictors of influenza according to different types of influenza in adult patients admitted to medical wards and ICUs, Toronto, 2007/
8 influenza season
Predictor Influenza A(H3N2) Influenza B
Odds ratio (95% CI) Odds ratio (95% CI)
Univariable analysis Multivariable analysis Univariable analysis Multivariable analysis
Age ≥65 years 1.3 (0.7–2.3) 1.5 (1.0–2.3) 1.4 (0.9–2.1)
Female gender 0.9 (0.6–1.5) 1.1 (0.8–1.6)
Residence in long-term care facility 1.1 (0.5–2.2) 1.3 (0.8–2.1)
Triage temperature ≥38.0°C 5.5 (3.4–9.0) 4.8 (2.8–8.0) 3.6 (2.5–5.1) 3.0 (2.1–4.5)
Respiratory symptoms in ED 2.4 (1.4–4.3) 1.8 (1.0–3.4) 3.0 (2.0–4.6) 1.8 (1.1–3.0)
Admission diagnosis
Pneumonia/other respiratory infection 2.5 (1.5–4.1) 1.2 (0.7–2.1) 2.6 (1.8–3.7) 1.7 (1.1–2.6)
COPD/asthma/respiratory failure NOS 1.6 (0.8–3.2) 2.2 (1.4–3.5) 2.2 (1.3–3.8)
ICU admission 0.5 (0.3–0.8) 0.7 (0.5–1.0)
Week with >15% specimens positive 6.0 (3.2–11.5) 6.5 (3.3–12.7) 7.5 (4.6–12.2) 7.0 (4.3–11.4)
Abbreviations: ED: emergency department; COPD: chronic obstructive pulmonary disease; NOS: not otherwise specified
Table 2 Predictors of influenza in adult patients admitted to medical wards and ICUs, Toronto, 2007/8 influenza season
Predictor Univariable analysis Multivariable analysis
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
Age ≥65 years 1.2 (0.9–1.6) 0.1889
Female gender 1.1 (0.9–1.4) 0.4470
Residence in long-term care facility 1.3 (0.9–1.8) 0.1524
Triage temperature ≥38.0°C 3.8 (2.9–4.9) <0.0001 3.1 (2.3–4.1) <0.0001
Respiratory symptoms in ED 2.7 (2.0–3.7) <0.0001 1.7 (1.2–2.4) 0.0030
Admission diagnosis
Pneumonia/other respiratory infection 2.5 (1.9–3.2) <0.0001 1.8 (1.3–2.4) 0.0006
COPD/asthma/respiratory failure NOS 2.1 (1.5–3.0) <0.0001 2.3 (1.6–3.4) <0.0001
ICU admission 0.7 (0.5–0.9) 0.0057
Week with >15% specimens positive 4.1 (3.1–5.5) <0.0001 4.2 (3.1–5.7) <0.0001
Abbreviations: ED: emergency department; COPD: chronic obstructive pulmonary disease; NOS: not otherwise specified
840 Eur J Clin Microbiol Infect Dis (2010) 29:835–843geriatrics, respirology, or infectious diseases wards with
any diagnosis had influenza [16].
These studies, and that of Babcock et al., also found that
clinical signs and symptoms are of limited value in
diagnosing influenza [17]. Walsh et al. found that, during
a one-year epidemic period, the complex of cough,
temperature of 38°C or higher, and illness duration of
7 days or less in older adults with a cardiopulmonary
admitting diagnosis yielded a sensitivity of 78% and a
specificity of 73%, a positive predictive value of 40%, and
a negative predictive value of 91% [15]. However, other
authors have, in general, not been able to identify
symptoms complexes with positive or negative predictive
values much above 50%. As Call et al. noted in their 2005
meta-analysis: “Unfortunately, no specific symptom or
combination of symptoms is diagnostic of this common
infection” [18].
The goal of this study, however, was not to identify
symptom complexes that could diagnose influenza, but,
rather, to identify populations of patients in whom the
probability of influenza was high enough that either
diagnostic testing or empiric antiviral therapy were war-
ranted. An increasing number of studies suggest that
specific antiviral therapy is effective in reducing the
morbidity and mortality associated with influenza [7, 8],
and current guidelines for both seasonal and pandemic
influenza recommend the treatment of patients requiring
hospitalization for influenza [19, 20]. In outpatients, early
therapy with specific antivirals is more effective than later
therapy [21], and there is good evidence for bacterial
infection requiring hospitalization that early, effective anti-
bacterial therapy improves outcomes [22–24]. Our data
may be particularly important for clinicians considering
empiric antiviral therapy, where understanding the pre-test
probability of acute infection is needed for rational use.
As in other studies of influenza in adults, our data
suggest that reverse transcriptase polymerase chain reaction
(RT-PCR) is significantly more sensitive than viral culture
or DFA for influenza diagnosis, and these tests are, in turn,
more sensitive than commercial rapid influenza tests. In
adult patients requiring hospital admission, RT-PCR is the
only diagnostic test with adequate performance character-
istics for the diagnosis of influenza [19].
There are a number of limitations to our study. Only
63% of eligible patients were tested for influenza, suggest-
ing that the proportion of persons actually infected might be
significantly higher than our estimate. The fact that patients
in whom clinicians accepted recommended orders were
Table 4 Likelihood of influenza in different groups of screened patients admitted to medical wards and ICUs in Toronto, 2007/8 influenza season
Admitting diagnosis/clinical characteristics Triage
temperature
Timing during
season
Likelihood of influenza
(95% CI)
COPD/asthma exacerbation
a ≥38°C Peak weeks 0.35 (0.14–0.56)
≥38°C Any time 0.32 (0.17–0.46)
Any Peak weeks 0.17 (0.12–0.23)
Any Any 0.13 (0.10–0.16)
<38°C Early or late
weeks
0.05 (0.02–0.09)
Respiratory infection
b ≥38°C Peak weeks 0.30 (0.22–0.38)
≥38°C Any time 0.20 (0.15–0.25)
Any Peak weeks 0.20 (0.16–0.24)
Any Any 0.13 (0.11–0.16)
<38°C Early or late
weeks
0.04 (0.01–0.06)
Respiratory symptoms reported in ED ≥38°C Peak weeks 0.31 (0.25–0.38)
≥38°C Any time 0.21 (0.17–0.26)
Any Peak weeks 0.15 (0.13–0.17)
Any Any 0.10 (0.09–0.11)
Diagnosis other than respiratory infection or COPD exacerbation, but with
respiratory symptoms in ED
≥38°C Early or late
weeks
0.06 (0.00–0.12)
<38°C Early or late
weeks
0.01 (0.00–0.12)
Abbreviations: ED: emergency department; COPD: chronic obstructive pulmonary disease
aCOPD/asthma exacerbation includes “exacerbation of COPD (chronic obstructive pulmonary disease)”, “exacerbation of asthma”, and “respiratory failure
NOS (not otherwise specified)”
bRespiratory infection includes “pneumonia” and “other respiratory infection”
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have a high-risk diagnosis suggests that clinicians were
selecting out patients more likely to have influenza for
testing. As in Babcock et al.’s study [17], it is possible that
patients whose clinicians did not order specimens did not
have influenza. However, other unknown biases may have
existed. Data collection by chart review limited the number
of risk factors that might have been considered, and meant
that we could not consider any differences that might have
been found between vaccinated and unvaccinated persons.
In addition, we assessed only respiratory symptoms overall
rather than individual specific respiratory symptoms (e.g.,
cough, shortness of breath). Although our results are similar
to those of studies in other seasons and geographic areas,
there may still be significant year-to-year and area-to-area
variation. In support of this, risk factors for infection with
influenza A(H3N2) and influenza B appear to be somewhat
different in our analysis. In addition, as expected, patients
admitted with influenza during weeks with predominant A
(H1N1) activity were younger than others [25]. Although
there were too few A(H1N1) infections diagnosed to
compare risk factors for A(H1N1) compared to A(H3N2)
and B infections, such predictors may be different, in part,
because patients infected with influenza A(H1N1) are
expected to be younger than patients infected with
influenza A(H3N2) or B [25]. Finally, patients who are
admitted to hospital with influenza infection likely do not
constitute a homogenous group. The proportion of patients
who need specific antiviral therapy to control influenza
infection versus the proportion who are suffering from a
complication of influenza but are able to control viral
replication themselves remains unknown. Further study to
define the causes of hospitalization due to influenza and the
potential of antiviral therapy are clearly needed.
The identification of patients shedding influenza virus is
also important for infection prevention. If additional
precautions for patients admitted with influenza are an
important element of the control of transmission of
influenza in acute care hospitals, then our data suggest that
additional precautions should be implemented for all
patients with respiratory infections and COPD or asthma
exacerbations during the influenza season, until the results
of influenza testing rule out influenza. The cost and impact
on patient care of such an approach highlights the need for
a better understanding of when patients with influenza are
infectious and of the epidemiology of healthcare-associated
influenza transmission.
In conclusion, we believe that, in febrile patients with
suspected respiratory infection or exacerbation of COPD
or asthma, influenza testing and empiric antiviral therapy
may be warranted during influenza seasons. During
weeks in which >15% of surveillance specimens are
expected to be positive for influenza, testing and
empirical treatment might be indicated in any patient
with respiratory symptoms. This approach may not
contribute to the development of resistance, as the
treatment of patients who do not have influenza does
not create selective pressure for drug resistance, because
current antivirals are influenza-specific.
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